Agilent Technologies, Inc.

US$174.76As of Sun 8 Nov 2026, 12:00 UTC
NYSE:AHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 15.76%
Div yield 0.58%
ROE 20.97%
Diagnostics & Research
Beta (5Y) 1.24
PE TTM 34.46
TSR TTM 20.30%
Mkt cap US$49.27B
ROIC 16.89%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$202
15.79%
27.44%
Hold 8|12|5|7|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
2.76
2.92
3.26
3.44
8.61%
11.90%
26.66%
31.91%
Revenue$B
5.883
6.044
6.267
6.305
10.72%
14.53%
15.02%
12.17%
Peers (US$49.27B)
Cap (US$)
PE
53.26B
45.58x
45.05B
—
44.96B
395.6x
44.80B
32.93x
Capital
TTM
5Y
10Y
Leveragex
0.282
(0.107)
(0.101)
EBIT/Intx
0.409
0.422
0.484
Own earn%
(70.43)
(124.09)
(110.15)
Sh yield%
35.25
7.59
8.15
Owners
Insiders/Inst%
1.77
69.84
Short interest%
3.36
SBC / revenue%
0.31
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
30–34
$1 testx
4.2
Incr. ROIC%
3

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide, including liquid chromatography and mass spectrometry systems, genomics products, services, consumables and software, and gas chromatography, spectroscopy and vacuum technology. It sells through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce.